Filing Details

Accession Number:
0001209191-15-055608
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-23 12:33:45
Reporting Period:
2015-06-19
Filing Date:
2015-06-23
Accepted Time:
2015-06-23 12:33:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1121702 Metabolix Inc. MBLX Miscellaneous Plastics Products (3080) 043158289
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1603544 Birchview Fund Llc 688 Pine Street, Suite D
Burlington VT 05401
Yes No No No
1618112 Birchview Partners, Llc 688 Pine Street, Suite D
Burlington VT 05401
Yes No No No
1618205 Birchview Capital, Lp 688 Pine Street, Suite D
Burlington VT 05401
Yes No No No
1618206 Birchview Capital Gp, Llc 688 Pine Street, Suite D
Burlington VT 05401
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-06-19 43,700 $3.32 710,366 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrants Acquisiton 2015-06-19 39,330 $0.13 39,330 $3.98
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
39,330 2015-06-19 2019-06-19 No 4 P Indirect
Footnotes
  1. The reported securities are included within 43,700 units of Issuer securities (the "Units") purchased by Birchview Fund, LLC (the "Fund") for $3.4325 per Unit pursuant to a Securities Purchase Agreement, dated June 15, 2015 by and among the Issuer, the Fund and certain other qualified institutional and individual investors. Each Unit consists of one share of of the Issuer's Common Stock, par value $0.01 per share ("Common Stock") and and nine-tenths of a Common Stock warrant to purchase one share of Common Stock at an exercise price of $3.98 per share (subject to adjustment in the event of stock splits, stock dividends, reclassifications and the like) (the "Warrant").
  2. The shares of Common Stock reported herein give effect to the 1-for-6 reverse stock split which became effective in accordance with the terms of the Certificate of Amendment to the Company's Amended and Restated Certificate of Incorporation filed with the Secretary of State of Delaware on May 26, 2015.
  3. Birchview Partners, LLC (the "Manager") is a member of Birchview Capital GP, LLC (the "GP"), which is the general partner of Birchview Capital, LP (the "Investment Manager"), the investment Manager of the Fund. The Manager disclaims Section 16 beneficial ownership of the shares of Common Stock, the Warrant and the shares of Common Stock underlying the Warrant, held by the Fund (collectively, the "Fund Securities") and this report shall not be deemed an admission that such reporting person is the beneficial owner of such Fund Securities, except to the extent of its pecuniary interest, if any, in the Fund Securities by virtue of its membership interest in the Fund.
  4. (Continued from Footnote 3) The GP and Investment Manager disclaim Section 16 beneficial ownership of the Fund Securities and this report shall not be deemed an admission that such reporting persons are the beneficial owners of such Fund Securities, except to the extent of their pecuniary interest, if any, in the Fund Securities by virtue of their management fee interest in the Fund.
  5. Matthew Strobeck, the sole member of the GP, serves as the representative of the GP, the Investment Manager and the Fund on the Issuer's board of directors.